Detection of bcr-abl transcripts in philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation

Blood

Volumn 89, Issue 7, 1997, Pages 2602-2609

  Radich, Jerald ^a   Gehly, Gene ^a   Lee, Arthur ^a   Avery, Rachel ^a   Bryant, Eileen ^a   Edmands, Scott ^a   Gooley, Ted ^a   Kessler, Peter ^a   Kirk, Judy ^a   Ladne, Paula ^a   Thomas, E D ^a   Appelbaum, Frederick R ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; HYBRID PROTEIN; MESSENGER RNA; METHOTREXATE; THYMOCYTE ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CHILD; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYBRID GENE; INFANT; MALE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR;

EID: 0031002040     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.7.2602     Document Type: Article

References (37)

1. Bloomfield CD, Goldman AI, Alimena G, Berger R, Borgstrom GH, Brandt L, Catovsky D, de la Chapelle A, Dewald GW, Garson OM, Garwicz S, Golomb HM, Hossfeld DK, Lawler SD, Mitelman F, Nilsson P, Pierre RV, Philip P, Prigogina E, Rowley JD, Sakurai M, Sandberg AA, Seeker-Walker LM, Tricot G, Van Den Berghe H, Van Orshoyen A, Vuopio P, Whang-Peng J: Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. Blood 67:415, 1986
2. Secker-Walker LM, Craig JM, Hawkins JM, Hoffbrand AV: Philadelphia positive acute lymphoblastic leukemia in adults: Age distribution, BCR breakpoint and prognostic significance. Leukemia 5:196, 1991
3. 3. Hematol Oncol 7:367, 1989
4. Forman SJ, O'Donnell MR, Nademanee AP, Snyder DS, Bierman PJ, Schmidt GM, Fahey JL, Stei AS, Parker PM, Blume KG: Bone marrow transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 70:587, 1987
5. Barrett AJ, Horowitz MM, Ash RC, Atkinson K, Gale RP, Goldman JM, Henslee-Downey PJ, Herzig RH, Speck B, Zwaan FE, Bortin MM: Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 79:3067, 1992
6. Radich J, Sanders J, Buckner CD, Martin PJ, Petersen FB, Hansen JA: Second allogeneic bone marrow transplants for patients relapsing after initial transplant with TBI-containing regimens. J Clin Oncol 11:304, 1993
7. Mrsic M, Horowitz MM, Atkinson K, Biggs JC, Champlin RE, Ehninger G, Gajewski JL, Gale RP, Herzig RH, Prentice HG, Rozman C, Sobocinski KA, Speck B, Bortin MM: Second HLA-identical sibling transplants for leukemia recurrence. Bone Marrow Transplant 9:269, 1992
8. Meyers JD, Flournoy N, Sanders JE, Reed EC, Shepp DH, Thomas ED: Prophylactic use of human leukocyte interferon after allogeneic marrow transplantation. Ann Intern Med 107:809, 1987
9. Uckun FM, Gajl-Peczalska KJ, Kersey JH, Houston LL, Vallera DA: Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia. J Exp Med 163:347, 1986
10. 1 translocation. Nature 315:758, 1985
11. Hermans A, Heisterkamp N, von Lindern M, van Baal S, Meijer D, van der Plas D, Wiedemann LM, Groffen J, Bootsma D, Grosveld G: Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia. Cell 51:33, 1987
12. Clark SS, McLaughlin J, Timmons M, Pendergast AM, BenNeriah Y, Dow LW, Crist W, Rovera G, Smith SD, Witte ON: Expression of a distinctive BCR-ABL oncogene in Ph-positive acute lymphocytic leukemia (ALL). Science 239:775, 1988
13. Schaefer-Rego K, Arlin Z, Shapiro LG, Mears JG, Leibowitz D: Molecular heterogeneity of adult Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer Res 48:866, 1988
14. Clark SS, McLaughlin J, Crist WM, Champlin R, Witte ON: Unique forms of the abl tyrosine kinase distinguish Ph-positive CML from Ph-positive ALL. Science 235:85, 1987
15. Lee A, Kirk J, Edmands S, Radich J: Multiplex PCR for the simultaneous detection of the p190 and p210 transcript. PCR Methods Appl 4:283, 1995
16. Sawyers CL, Timson L, Kawasaki ES, Clark SS, Witte ON, Champlin R: Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by the polymerase chain reaction. Proc Natl Acad Sci USA 87:563, 1990
17. Delage R, Soiffer RJ, Dear K, Ritz J: Clinical significance of BCR-ABL gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia. Blood 78:2759, 1991
18. Hughes TP, Morgan GJ, Martiat P, Goldman JM: Detection of residual kukemia after bone marrow transplantation for chronic myeloid leukemia: Role of polymerase chain reaction in predicting relapse. Blood 77:874, 1991
19. Roth MS, Antin JH, Ash R, Valeri TH, Gotlieb M, Silver SM, Ginsburg D: Prognostic significance of Philadelphia chromosomepositive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myeloid leukemia. Blood 79:216, 1992
20. Lee M, Khouri I, Champlin R, Kanarjian H, Talpaz M, Trujillo J, Freireich E, Deisseroth A, Stass S: Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantation. Br J Haematol 82:708, 1992
21. Cross NCP, Feng L, Chase A, Bungey J, Hughes TP, Goldman JM: Competitive polymerase chain reaction to estimate the number of bcr-abl transcripts in chronic myeloid leukemia patients after bone marrow transplant. Blood 82:1929, 1993
22. Miyamura K, Tahara T, Tanimoto M, Morishita Y, Kawashima K, Morishima Y, Saito H, Tsuzuki S, Takeyama K, Kodera Y, Matsuyama K, Hirabayashi N, Yamada H, Naito K, Imai K, Sakamaki H, Asai O, Miqutani S: Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogeous leukemia without clinical relapse: A study of 64 patients. Blood 81:1089, 1993
23. Radich J, Gehly G, Gooley T, Bryant E, Clift RA, Collins S, Edmands S, Kirk J, Lee A, Kessler P, Schoch G, Buckner CD, Sullivan KM, Appelbaum FR, Thomas ED: PCR detection of the bcr-abl fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: Results and implications in 346 patients. Blood 85:2632, 1995
24. Gehly GB, Bryant EM, Lee AM, Kidd PG, Thomas ED: Chimeric bcr-abl messenger RNA as a marker for minimal residual disease in patients transplanted for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 78:458, 1991
25. Miyamura K, Tanimoto M, Morishima Y, Horibe K, Yamamoto K, Akatsuka M, Kodera Y, Kohima S, Matsuyama K, Hirabayashi N, Yazaki M, Imai K, Onozawa Y, Kanamaru A, Misutai S, Saito H: Detection of Philadelphia chromosome-positive acute lymphoblastic leukemia by polymerase chain reaction: Possible eradication of minimal residual disease by marrow transplantation. Blood 79:1366, 1992
26. Mitterbauer G, Fodinger M, Scherrer R, Knobl P, Jager U, Laczika K, Schwarzinger I, Gaiger A, Geissler K, Greinix H, Kalhs P, Linkesch W, Lechner K, Mannhalter C: PCR-monitoring of minimal residual leukaemia after conventional chemotherapy and bone marrow transplantation in BCR-ABL positive acute lymphoblastic leukaemia. Br J Haematol 89:937, 1995
27. Radich J, Kopecky K, Boldt D, Head D, Slovak M, Appelbaum F, Lee A, Kirk J, Gehly G: Detection of bcr-abl fusion genes in adult acute lymphoblastic leukemia by the polymerase chain reaction. Leukemia 8:1688, 1994
28. Kwok S, Higushi R: Avoiding false positives with PCR. Nature 339:237, 1989
29. Storb R, Deeg HJ, Whitehead J, Appelbaum F, Bearty P, Bensinger W, Buckner CD, Clift R, Doney K, Farewell V, Hansen J, Hill R, Lum L, Martin P, McGuffin R, Sanders J, Stewart P, Sullivan K, Witherspoon R, Yee G, Thomas ED: Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 313:729, 1986
30. Pepe MS, Longton G, Pettinger M, Mori M, Fisher LD, Storb R: Summarizing data on survival, relapse, and chronic GVHD after bone marrow transplantation: Motivation and description of a new method. Br J Hematol 83:602, 1992
31. Kalbfleish JD, Prentice RI: The Statistical Analysis of Failure Time Data. New York, NY, Wiley, 1980
32. van Rhee F, Hochhaus A, Lin F, Melo JV, Goldman JM, Cross NCP: p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias. Blood 87:5213, 1996
33. Lugo TG, Pendergast AM, Muller AJ, Witte ON: Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 247:1079, 1990
34. Kelliher M, Knott A, McLaughlin J, Witte ON, Rosenberg N: Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene. Mol Cell Biol 11:4710, 1991
35. Voncken JW, Kaartinen V, Pattengale PK, Germeraad WTV, Groffen J, Heisterkamp N: BCR/ABL p210 and p190 cause distinct leukemia in transgenic mice. Blood 86:4603, 1995
36. Westbrook CA, Hooberman AL, Spino C, Dodge RK, Larson RA, Davey F, Wurster-Hill DH, Sobol RE, Schiffer C, Bloomfield CD: Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: A cancer and leukemia group B study (8762). Blood 12:2983, 1992
37. Radich J, Ladne P, Gooley T: PCR-based detection of unique immunoglobulin V-D-J gene rearrangements in acute lymphoblastic leukemia predicts relapse after allogeneic bone marrow transplantation. Biol Blood Marrow Transplant 1:24, 1995